| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26K | — | -97.9% |
| R&D Expense | $4.8M | — | -49.2% |
| SG&A Expense | $2.8M | — | -26.8% |
| Operating Income | -$7.6M | — | +37.3% |
| Net Income | -$7.2M | — | +34.4% |
| EPS (Basic) | -$4.31 | — | -1386.2% |
| EPS (Diluted) | -$4.31 | — | -1386.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.6M | -0.8% | +38.4% |
| Short-term Investments | $11.3M | -28.6% | -62.9% |
| Current Assets | $25.8M | -14.9% | -39.4% |
| Total Assets | $48.0M | -15.4% | -44.1% |
| Current Liabilities | $7.3M | -12.9% | -45.9% |
| Total Liabilities | $28.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.0M | — | +40.0% |
| Investing Cash Flow | $7.9M | — | -45.6% |
| Financing Cash Flow | $6K | — | — |
| -27.8% |
| Stockholders' Equity | $19.8M | -25.2% | -57.7% |